Speciality: Dermatology
Description:
A warm welcome to all the medical professionals in this interesting session on Role of Biologics in Psoriasis
Biologics have revolutionized the treatment of psoriasis, offering targeted therapies that specifically address the underlying mechanisms of the disease. Unlike traditional systemic treatments, which can have broad immunosuppressive effects, biologics target specific components of the immune system involved in psoriasis pathogenesis. This precision has led to significant improvements in efficacy and safety for patients with moderate to severe psoriasis. The most commonly used biologics in psoriasis treatment include TNF inhibitors, IL-12/23 inhibitors, IL-17 inhibitors, and IL-23 inhibitors. These biologics have demonstrated remarkable success in reducing psoriatic lesions, improving skin clearance, and enhancing the quality of life for patients. Clinical trials and real-world studies have shown that biologics can achieve rapid and sustained remission in many patients, with some experiencing near-complete resolution of their symptoms.
Therefore, get an overall knowledge of updated Role of Biologics in Psoriasis
See More Webinars @ Hidoc Webinars
1.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
2.
Research uncovers hidden Australian skin cancer epidemic
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
5.
The American College of Physicians updated its recommendations for colorectal cancer screening.
1.
Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options
2.
The Role of Alanine Aminotransferase in Liver Health and Disease
3.
Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation